erythromycin has been researched along with Obesity, Morbid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frizzi, JD; Gustafson, RJ; Wilkinson, NW | 1 |
Miller, SD | 1 |
1 trial(s) available for erythromycin and Obesity, Morbid
Article | Year |
---|---|
The effect of erythromycin on bile excretion and proximal small bowel motility following divided gastric bypass surgery: a prospective randomized placebo-controlled trial.
Topics: Bile; Biliary Tract; Double-Blind Method; Duodenum; Erythromycin; Gastric Bypass; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Imino Acids; Liver; Obesity, Morbid; Postoperative Period; Prospective Studies; Radionuclide Imaging | 2002 |
1 other study(ies) available for erythromycin and Obesity, Morbid
Article | Year |
---|---|
Madura foot: treatment of Nocardia nova infection with antibiotics alone.
Topics: Administration, Oral; Adult; Amikacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Follow-Up Studies; Foot Bones; Foot Dermatoses; Humans; Infusions, Intravenous; Nocardia; Nocardia Infections; Obesity, Morbid; Severity of Illness Index; Treatment Outcome | 2001 |